![]() Blue Turtle Bio We're creating the next generation therapeutic using our patent pending platform technology. | ![]() Q32 Bio Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases. | ![]() Adhesion Therapeutics Adhesion Therapeutics (also known as Celeris Therapeutics) is a company that designs molecular glue degraders. | |||
Founding Date | Founding Date 2014 | Founding Date N/A | Founding Date 2013 | Founding Date 2016 | Founding Date 2021 |
Type | Type Private | Type Private | Type Private | Type Private | Type Private |
Tags | |||||
Locations | Locations San Francisco, US HQ | Locations Cambridge, US HQ | Locations New York, US HQ London, GB | Locations Babraham, GB HQ Histon, GB | Locations Menlo Park, US HQ Graz, AT London, GB |
Employees | Employees 1 | Employees 348% decrease | Employees 5614% decrease | Employees 1644% decrease | Employees 433% decrease |
Funding | |||||
Latest funding round | Latest funding round $ 100k (almost 10 years ago) | Latest funding round $ 60m (over 5 years ago) | Latest funding round $ 16m (over 5 years ago) | Latest funding round $ 41.5m (almost 6 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 100k | Total funding raised $ 106m | Total funding raised $ 25.6m | Total funding raised $ 41.5m | Total funding raised N/A |

Q32 Bio is a biotechnology company developing treatments for patients with severe autoimmune and inflammatory diseases.
View company
Koneksa Health is a company that develops a digital biomarker platform.
View company
Bit Bio is a company that develops a cell reprogramming platform.
View company
Adhesion Therapeutics (also known as Celeris Therapeutics) is a company that designs molecular glue degraders.
View company